A carregar...
Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA: Comment on "Ethics in HTA: Examining the ‘Need for Expansion’"
Abrishami, Oortwijn, and Hofman (AOH) attribute to me a position I do not hold and an argument I did not make. The purpose of this note is make clear what my position actually is and to clarify the main differences between health technology assessment (HTA) and cost-effectiveness analysis (CEA).
Na minha lista:
| Publicado no: | Int J Health Policy Manag |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Kerman University of Medical Sciences
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6885861/ https://ncbi.nlm.nih.gov/pubmed/31779302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/ijhpm.2019.73 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|